ACSL4 and prostate carcinoma: Notably, ACSL4 (acyl-CoA synthetase long-chain family member 4) has emerged as a significant player, as its high expression has been linked to promoting prostate cancer growth, invasion, and hormonal resistance, thereby contributing to disease aggressiveness (Wu et al., 2015).